THE Indonesia granted emergency license for the new coronavirus vaccine developed by the British-Swedish pharmaceutical industry AstraZeneca in collaboration with the University of Oxford, announced today Penny K. Luquito, head of the Indonesian National Food and Drug Administration, during a press conference.
More than a million doses of the product arrived in Indonesia late Monday night through the COVAX program, led by the World Health Organization.
So far, according to AMPE, the Southeast Asian country has received about 38 million doses of the Chinese biotechnology company Sinovac Biotech vaccine for the new coronavirus. Some of them have already been utilized in the context of the mass immunization campaign launched in January.
Indonesia has recorded as this stage over 37,200 deaths because of COVID-19 in total 1.38 million cases of SARS-CoV-2.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
